Skip to content Skip to navigation

20 / 20 Blog Archive

Oct 31 2019 | Posted In: 20/20 Blog
Palo Alto, CA —The ability to obtain high resolution crystal structures of proteins has shifted drug design into a new age. Computationally aided drug design is being increasingly used to expedite and simplify the drug discovery process. The ability to visualize the protein binding site allows...
Oct 30 2019 | Posted In: 20/20 Blog
Santa Cruz, CA — Members of the Mahajan Lab attended Stanford’s Department of Structural Biology Scientific Retreat held in Santa Cruz at the Chaminade Resort. The retreat gave students, post-doctoral fellows, and faculty the opportunity to share their most recent research findings.
Oct 16 2019 | Posted In: 20/20 Blog
Palo Alto, CA — A gene therapy clinical trial for Dry Age Related Macular Degeneration (AMD) is beginning at the Byers Eye Institute under the direction of Vinit Mahajan M.D., Ph.D., associate professor and Vice Chair for Research in Ophthalmology. The trial is in partnership with Gyroscope, an ...
Oct 14 2019 | Posted In: 20/20 Blog
Palo Alto, CA – Dry macular degeneration is a common eye condition that usually occurs in people over 50. It is characterized by blurring of the central vision along with a decreased ability to see colors and fine details. Although it does not impact peripheral vision, it can impact every day...
Sep 28 2019 | Posted In: 20/20 Blog
Portland, OR — Vinit Mahajan M.D., Ph.D., Vice Chair of Research for the Stanford Ophthalmology Department, traveled to Portland, Oregon to give the keynote lecture at the 10th Annual Gained in Translation Symposium held at the OHSU Knight Cancer Research Building.